Functional Target Discovery, Preclinical Models and New Drugs in Oncology II

Programm

• 13:00 20 Min. 5 Min.

  • Invited Lecture

  Towards mechanism-based combination therapies: Understanding tumor evolution during therapy response and resistance

  EMBO Young Investigator Lecture

  • Anna Obenauf (Vienna / AT)
• 13:25 20 Min. 5 Min.

  • Invited Lecture

  Once there was the perfect anti-cancer target YAP...

  • Georg Halder (Leuven / BE)
• 13:50 12 Min. 3 Min.

  • Abstract Lecture

  Design and Synthesis of Irreversible Inhibitors Targeting the Checkpoint Kinase 2 (CHK2)

  • Matthias Gehringer (Tübingen / DE)

   Functional target discovery, preclinical models and new drugs in oncology
• 14:05 12 Min. 3 Min.

  • Abstract Lecture

  Patient-by-Patient deep transfer learning and automated analysis tools for image-based functional drug sensitivity profiling of patient-derived tumor-cell spheroids

  • Sina Oppermann (Heidelberg / DE)

   Functional target discovery, preclinical models and new drugs in oncology
• 14:20 12 Min. 3 Min.

  • Abstract Lecture

  First-in-class ultralong target residence time p38alpha inhibitors as a novel mitosis-targeted therapy for colorectal cancer

  • Daniel Dauch (Tübingen / DE)

   Functional target discovery, preclinical models and new drugs in oncology